Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells

被引:23
作者
Kozel, TR
Tabuni, A
Young, BJ
Levitz, SM
机构
[1] UNIV NEVADA, CELL & MOLEC BIOL PROGRAM, RENO, NV 89557 USA
[2] BOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, BOSTON, MA 02118 USA
[3] BOSTON UNIV, MED CTR, DEPT MED, UNIV HOSP, BOSTON, MA 02118 USA
关键词
D O I
10.1128/IAI.64.6.2336-2338.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies demonstrated that, following opsonization with normal human serum (NHS), phagocytes bind greater numbers of small-capsule Cryptococcus neoformans cells than yeast cells with large capsules. The present study tested the hypothesis that suboptimal deposition of opsonic C3 fragments contributes to this disparity. C. neoformans was grown under conditions promoting large or small capsules and was incubated at various concentrations in NHS. At low concentrations of yeast cells (125 cells per mu l of NHS), the deposition of C3 fragments per unit of capsule volume and the binding of yeast cells to cultured human monocytes were similar for yeast cells having large and small capsules. However, at higher cell concentrations, large-capsule cells exhibited suboptimal coating with C3 fragments and markedly diminished monocyte binding compared with small-capsule cells. Thus, the inverse correlation between capsule size and phagocyte binding can be overcome by conditions promoting optimal C3 deposition.
引用
收藏
页码:2336 / 2338
页数:3
相关论文
共 19 条
[11]   INHIBITION OF PHAGOCYTOSIS BY CRYPTOCOCCAL POLYSACCHARIDE - DISSOCIATION OF ATTACHMENT AND INGESTION PHASES OF PHAGOCYTOSIS [J].
KOZEL, TR ;
MASTROIANNI, RP .
INFECTION AND IMMUNITY, 1976, 14 (01) :62-67
[12]   PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN-LEUKOCYTES STIMULATED BY CRYPTOCOCCUS-NEOFORMANS [J].
LEVITZ, SM ;
TABUNI, A ;
KORNFELD, H ;
REARDON, CC ;
GOLENBOCK, DT .
INFECTION AND IMMUNITY, 1994, 62 (05) :1975-1981
[13]   BINDING OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN CULTURED MACROPHAGES - REQUIREMENTS FOR MULTIPLE COMPLEMENT RECEPTORS AND ACTIN [J].
LEVITZ, SM ;
TABUNI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :528-535
[14]   GROWTH-INHIBITION OF CRYPTOCOCCUS-NEOFORMANS BY CULTURED HUMAN MONOCYTES - ROLE OF THE CAPSULE, OPSONINS, THE CULTURE SURFACE, AND CYTOKINES [J].
LEVITZ, SM ;
FARRELL, TP .
INFECTION AND IMMUNITY, 1990, 58 (05) :1201-1209
[15]   PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF HUMAN-LYMPHOCYTES ACTIVATED BY INTERLEUKIN-2 TO DIRECTLY INHIBIT GROWTH OF CRYPTOCOCCUS-NEOFORMANS INVITRO [J].
LEVITZ, SM ;
DUPONT, MP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1490-1498
[16]  
MACHER AM, 1978, J IMMUNOL, V120, P1686
[17]   IN-VITRO PHAGOCYTOSIS AND INTRACELLULAR FATE OF VARIOUSLY ENCAPSULATED STRAINS OF CRYPTOCOCCUS-NEOFORMANS [J].
MITCHELL, TG ;
FRIEDMAN, L .
INFECTION AND IMMUNITY, 1972, 5 (04) :491-&
[18]   PHAGOCYTOSIS OF CRYPTOCOCCUS-NEOFORMANS BY NORMAL AND THIOGLYCOLATE-ACTIVATED MACROPHAGES [J].
SWENSON, FJ ;
KOZEL, TR .
INFECTION AND IMMUNITY, 1978, 21 (03) :714-720
[19]   EFFECTS OF STRAIN VARIATION, SEROTYPE, AND STRUCTURAL MODIFICATION ON KINETICS FOR ACTIVATION AND BINDING OF C3 TO CRYTOCOCCUS-NEOFORMANS [J].
YOUNG, BJ ;
KOZEL, TR .
INFECTION AND IMMUNITY, 1993, 61 (07) :2966-2972